INDIA – Drug firm Zydus Cadila has received final approval from the US health regulator to market Tofacitinib extended-release tablets, used to treat rheumatoid arthritis, in the American market. The…
Read MoreZydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivity
